DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Azuma J, Ohno M, Kubota R. et al.
NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy.
Eur J Clin Pharmacol 2013;
69: 1091-1101
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.